Latest News of BIO
Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
By Yahoo! Finance |
20 hours ago
Terry Rosen, CEO, discussed the direct move to human studies without preclinical work with Fallu and CA. Atrumid program's next steps are being planned post ARC nine data. The strategy for IO-naive re...
Blue Shield Of California Push For Cheaper Biosimilars Could Disrupt Market
By Forbes |
1 day ago
Blue Shield of California is offering a biosimilar of Humira, called Idacio, at a low price of $525, bypassing traditional pharmacy benefit managers. This move aims to reduce costs for patients and ma...
Gilead's earnings beat by a wide margin, and biotech raises guidance
By MarketWatch |
1 day ago
Gilead Sciences Inc. saw a 2% rise in stock during after-hours trading following strong Q3 earnings and increased guidance, driven by high demand for its HIV and COVID-19 treatments. Net income was $1...
-
White House Legalizes All Gain-Of-Function Research to Build More BIOWEAPONS
By The Washington Standard | 1 day agoThe White House has legalized gain-of-function research, allowing the bioweapons industry to develop more potent viruses. The new rules aim to oversee research involving pathogens with enhanced pandem...
-
Tevogen Bio partners Microsoft for HPV treatment
By Yahoo! Finance | 1 day agoTevogen Bio's Tevogen.AI, in partnership with Microsoft, aims to develop a CTL treatment for HPV using advanced tools. Their ExacTcell technology targets HPV antigens for potential new drug developmen...
-
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings Call Highlights: Revenue Growth and Positive Net ...
By Yahoo! Finance | 1 day agoThe CEO discusses the normalized demand environment in the US, emphasizing the essential role of flow cytometry in biology labs. The CFO expects sequential revenue growth in Q4 and outlines strategies...
-
Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline
By Yahoo! Finance | 1 day agoA list of top NYSE penny stocks includes Nuvation Bio Inc. Amid US Federal Reserve rate cuts, small-cap stocks are gaining attention for potential growth. Analysts see value in small-cap investments, ...
-
Sen. Marco Rubio on how Trump is winning over voters and his Day 1 priorities
By CBS News | 1 day agoSen. Marco Rubio discusses key voters for Trump's campaign, Florida's abortion amendment, and Trump's priorities. CBS News projects Bernie Moreno to defeat Sen. Sherrod Brown in Ohio's Senate race....
-
How can dubious 'misgendering' claims threaten to destroy this law...
By New York Post | 2 days agoA Pace Law School student faces severe consequences for alleged misgendering during a panel discussion, sparking controversy over free speech and Title IX. Critics warn against weaponizing anti-discri...
-
Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920
By Yahoo! Finance | 2 days agoRyan Saadi, CEO of Tevogen Bio, emphasizes the pressing need for sustainable healthcare solutions amid soaring U.S. healthcare costs. Tevogen focuses on developing innovative T cell therapies to addre...
-
Biotech Plummets On Worse-Than-Expected Eye Drug Sales
By Investor's Business Daily | 2 days agoApellis stock dropped significantly after lower-than-expected sales of its eye drug Syfovre in the third quarter, falling 1.7% sequentially. Despite the revenue miss, volume growth indicates sustained...
-
Can-Fite BioPharma Secures Australian Patent for Obesity Drug
By Yahoo! Finance | 2 days agoCan-Fite BioPharma's oral anti-obesity drug Namodenoson receives a patent in Australia until 2040. The drug aims to increase adiponectin hormone levels to reduce body fat, targeting the $12 billion gl...
-
Oak Hill Bio and Chiesi's OHB-607 trial enrols first European subject for BPD prevention
By Yahoo! Finance | 2 days agoOak Hill Bio and Chiesi Group have begun a Phase IIb clinical trial for OHB-607 to prevent bronchopulmonary dysplasia in premature infants across Europe....
-
BioCryst Pharmaceuticals Inc (BCRX) Q3 2024 Earnings Call Highlights: Strong ORLADEYO Growth ...
By Yahoo! Finance | 2 days agoHelen Thackray aims to demonstrate the effectiveness of Netherton syndrome treatment by focusing on skin penetration, target binding, and functional cure potential. Charlie Gayer expects continued ORL...
-
Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
By Yahoo! Finance | 2 days agoKrystal Biotech Inc (NASDAQ:KRYS) has seen over $250 million in net VYJUVEK revenue since August 2023. The company reported positive revenue growth, strong profitability, and progress in Europe. Howev...